These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15379654)

  • 1. Genotyping as a tool to predict adverse drug reactions.
    Güzey C; Spigset O
    Curr Top Med Chem; 2004; 4(13):1411-21. PubMed ID: 15379654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotyping of drug targets: a method to predict adverse drug reactions?
    Güzey C; Spigset O
    Drug Saf; 2002; 25(8):553-60. PubMed ID: 12113641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [State of the art of pharmacogenetic diagnostics in drug therapy].
    Kirchheiner J; Seeringer A; Brockmöller J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Oct; 49(10):995-1003. PubMed ID: 17013776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics of drug metabolising enzymes: importance for personalised medicine.
    Oscarson M
    Clin Chem Lab Med; 2003 Apr; 41(4):573-80. PubMed ID: 12747605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing.
    Shah RR
    Drug Saf; 2004; 27(3):145-72. PubMed ID: 14756578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic susceptibility to adverse drug reactions.
    Pirmohamed M; Park BK
    Trends Pharmacol Sci; 2001 Jun; 22(6):298-305. PubMed ID: 11395158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics and adverse drug reactions in diagnostic and clinical practice.
    Manolopoulos VG
    Clin Chem Lab Med; 2007; 45(7):801-14. PubMed ID: 17617019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic implications of polymorphisms in cytochromes and drug transporters].
    Münster E; Ziegler S; Brunner M
    Wien Med Wochenschr; 2005 Feb; 155(3-4):54-8. PubMed ID: 15791777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes.
    Kirchheiner J; Seeringer A
    Biochim Biophys Acta; 2007 Mar; 1770(3):489-94. PubMed ID: 17113714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.
    de Leon J; Susce MT; Murray-Carmichael E
    Mol Diagn Ther; 2006; 10(3):135-51. PubMed ID: 16771600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450 enzyme polymorphisms and adverse drug reactions.
    Pirmohamed M; Park BK
    Toxicology; 2003 Oct; 192(1):23-32. PubMed ID: 14511900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics: an opportunity for a safer and more efficient pharmacotherapy.
    Ingelman-Sundberg M
    J Intern Med; 2001 Sep; 250(3):186-200. PubMed ID: 11555122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Falls: the adverse drug reaction of the elderly and the impact of pharmacogenetics.
    Just KS; Schneider KL; Schurig M; Stingl JC; Brockmöller J
    Pharmacogenomics; 2017 Aug; 18(13):1281-1297. PubMed ID: 28776468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics-guided dose modifications of antidepressants.
    Seeringer A; Kirchheiner J
    Clin Lab Med; 2008 Dec; 28(4):619-26. PubMed ID: 19059066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics of the cytochromes P450.
    Daly AK
    Curr Top Med Chem; 2004; 4(16):1733-44. PubMed ID: 15579105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics and the concept of individualized medicine.
    Shastry BS
    Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of drug-metabolizing enzyme hydroxylation phenotypes in Hispanic populations: the CEIBA cocktail.
    de Andrés F; Sosa-Macías M; Lazalde-Ramos BP; Naranjo ME; Tarazona-Santos E; Llerena A;
    Drug Metabol Drug Interact; 2013; 28(3):135-46. PubMed ID: 23787463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapy.
    Ingelman-Sundberg M; Rodriguez-Antona C
    Philos Trans R Soc Lond B Biol Sci; 2005 Aug; 360(1460):1563-70. PubMed ID: 16096104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically determined adverse drug reactions involving metabolism.
    Lennard MS
    Drug Saf; 1993 Jul; 9(1):60-77. PubMed ID: 8347292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
    Lynch T; Price A
    Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.